Investment case
Align Technology, Inc.
ALGN · 6 developments mapped · last assessed 2026-09-27
Market Ontology has mapped 6 macro, policy, and market developments to Align Technology, Inc. since 2026-09-09. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for ALGN yet, so no modelled value is shown. The ALGN valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run ALGN on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Open question
Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook
Indirect read-through on dental industry demand and competitive landscape.
· Moves industry growth rate, competitive intensity
What changed, by assumption
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook
- 2026-09-09Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlook
- 2026-09-27Staar Surgical initiates $50M share repurchase program, lifting stock 7.5%
- 2026-09-27Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-27 | Staar Surgical initiates $50M share repurchase program, lifting stock 7.5% | watch | 1-3m | 0.30 |
| 2026-09-27 | Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program | watch | 3-12m | 0.30 |
| 2026-09-09 | Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance | watch | 1-3m | 0.30 |
| 2026-09-09 | Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance | watch | 1-3m | 0.30 |
| 2026-09-09 | Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook | mixed | 1-5d | 0.40 |
| 2026-09-09 | Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlook | mixed | 1-3m | 0.40 |